BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
31st Dec 17 Source: CRO
31st Dec 16 Source: CRO
- 2 more years available »
155th in Top Companies
- €491.6 million
- Michael O’Donnell CEO/Managing Director
- 9:52am Brexit drives two more American financial service groups to Dublin
- 9:27am Q&A: What does the collapse of Thomas Cook mean?
- 8:14am Revenues soar by 66% at virtual reality company VR Education
- 7:39am Record numbers of UK lawyers register in Ireland
- 7:23am Thomas Cook collapses after knife-edge rescue talks fail